FloridaMarijuana.net
JUNE 12, 2018
The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. One in 26 people will develop epilepsy in their lifetime. It is not fully known the genetic origins of epilepsy or if the condition is hereditary. appeared first on.
Project CBD
JULY 31, 2018
In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy. Six months later, Congress passed the Farm Bill, which legalized the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedicalJane
NOVEMBER 10, 2020
A newly published article in the Epilepsy & Behavior Journal highlights the findings of researchers at the University of Alabama at Birmingham after surveying healthcare providers on their attitudes and knowledge about cannabis, and has confirmed what most of us already knew– healthcare providers need more education on cannabis.
SpeedWeed
MARCH 27, 2021
The parents of a three-year-old boy with severe epilepsy have dropped a legal challenge after guidelines on prescribing cannabis were ‘clarified’. Medical cannabis was legalised in 2018, but few NHS prescriptions have been handed out due to NHS guidance. Read the entire article at BCC News. View original article.
WeedAdvisor
SEPTEMBER 24, 2019
On June 25, 2018, the U.S. GW Pharmaceuticals created the medication after studies showed surprising success treating severe childhood epilepsy, specifically Lennox-Gastaut Syndrome and Dravet Syndrome. The post Epidiolex CBD Epilepsy Drug Receives Approval in Europe appeared first on WeedAdvisor. In the U.S.,
MedicalJane
JUNE 12, 2020
A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes.
MMJ Recs
NOVEMBER 20, 2023
Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. For example, the discovery of CBD’s effectiveness in managing epilepsy led to the development of Epidiolex, the first FDA-approved medication derived from marijuana.
Expert insights. Personalized for you.
187 
Let's personalize your content